G01N 2333/70539
Mhc-molecules
Official title: MHC-molecules, e.g. HLA-molecules
G01N2333/70539 (Mhc-molecules) appears on 359 US grants and 748 published applications in this corpus.
Search patents in G01N- Granted patents
- 359
- Published applications
- 748
- Assignees
- 309
- Inventors
- 1,163
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 1 | 0 |
| 2002 | 3 | 7 |
| 2003 | 0 | 4 |
| 2004 | 1 | 14 |
| 2005 | 1 | 7 |
| 2006 | 0 | 9 |
| 2007 | 1 | 7 |
| 2008 | 1 | 11 |
| 2009 | 3 | 10 |
| 2010 | 4 | 12 |
| 2011 | 2 | 18 |
| 2012 | 2 | 13 |
| 2013 | 5 | 10 |
| 2014 | 7 | 17 |
| 2015 | 10 | 31 |
| 2016 | 11 | 44 |
| 2017 | 15 | 70 |
| 2018 | 47 | 67 |
| 2019 | 58 | 62 |
| 2020 | 41 | 68 |
| 2021 | 35 | 60 |
| 2022 | 31 | 63 |
| 2023 | 20 | 43 |
| 2024 | 29 | 36 |
| 2025 | 20 | 46 |
| 2026 | 11 | 19 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for inhibition of MICA/B shedding23 Jun 2026US 12,662,540 B2Dana-Farber Cancer Institute, Inc.
- CTL peptide epitopes and antigen-specific T cells, methods for their discovery, and uses thereof16 Jun 2026US 12,656,344 B2Oslo Universitetssykehus Hf
- Fibroblast and fibroblast-immunocyte combinations for treatment of subconcussive- and concussive-associated neurological damage9 Jun 2026US 12,648,968 B2SpinalCyte, LLC
- Method for stratifying the risk of BK virus nephropathy after a kidney transplant19 May 2026US 12,630,878 B2Assistance Publique-Hopitaux de Paris
- In vitro method for predicting mortality risk in patients suffering from shock28 Apr 2026US 12,614,637 B2Fundació Centre De Regulació GenòMica
- Mhc class i molecules8 Oct 2026US 2026/0308228 A1Immudex ApS
- Methods for characterization of antigen-binding molecules from biological samples27 Aug 2026US 2026/0250663 A110x Genomics, Inc.
- Neoantigen immunotherapies20 Aug 2026US 2026/0240970 A1Iogenetics, LLC
- Improved phox2b pc-car generation based on structure and saturation mutagenesis20 Aug 2026US 2026/0243766 A1The Children’s Hospital of Philadelphia
- Method for predicting the off-target binding of a peptide which binds to a target peptide presented by a major histocompatibility complex16 Jul 2026US 2026/0204354 A1Adaptimmune Limited
Most cited
By later US patents
- Compositions and methods of identifying tumor specific neoantigens70US 9,115,402 B2Dana-Farber Cancer Institute, Inc. · 2015
- Modified soluble T cell receptor63US 7,666,604 B2Immunocore Limited · 2010
- Peptides and combination of peptides for use in immunotherapy against various tumors45US 9,802,997 B2Immatics Biotechnologies GmbH · 2017
- Methods and reagents for quantitation of HLA-DR and CD11b expression on peripheral blood cells40US 6,423,505 B1Becton, Dickinson and Company · 2002
- Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development40US 9,791,443 B2Immatics Biotechnologies GmbH · 2017